Pradžia › Kraujo krešuliai › Indianas
Kraujo krešuliai klinikiniai tyrimai Indianas
7 tyrimai dėl Kraujo krešuliai ieško dalyvių vietose Indianas.
Miestai Indianas
Oficialus tyrimo tekstas (anglų kalba)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Profound Research, Powers Health Medical Group - Electrophysiology, Munster
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Indiana University, Indianapolis
- Blue Coast Research Center, LLC, Indianapolis
- Franciscan Physician Network, Indiana Heart Physicians, Indianapolis
- ir dar 2
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07175428Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Profound Research, Powers Health Medical Group, Munster
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07318610Aspiration Thrombectomy Using the Symphony or Prodigy System
- Profound Research, Munster
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07350499Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Indiana Medical Research, Merrillville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07430956ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Indiana Hemophilia and Thrombosis Center, Indianapolis
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628Rapid Evacuation and Access of Cerebral Hemorrhage Trial
- St Vincent Hospital/Goodman Campbell Brain and Spine, Indianapolis
Renkami dalyviai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-14 · NCT06870812Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.